Robert van Nostrand

Robert L.
van Nostrand is Independent Chairman at Yield10 Bioscience, Inc. since 2011.
Treasurer & Director at New York Biotechnology Association, Inc. Director at Brany LLC since 2011.
Director at ITI, Inc. (New York) since 2014.
Director at Sellas Life Sciences Group Ltd. since 2017.
Independent Director at SELLAS Life Sciences Group, Inc. since 2017.
Director at LikeMinds, Inc. (Massachusetts).
Member at Association of Biofinance Officers.
Formerly Chairman at Farmingdale College Foundation.
Independent Director at Achillion Pharmaceuticals, Inc. from 2007 to 2020.
Director at Achillion Pharmaceuticals, Inc. Director at Apex Bioventures Acquisition Corp.
from 2006 to 2009.
Independent Director at Enumeral Biomedical Holdings, Inc. from 2014 to 2018.
Director at Apex Bioventures LLC from 2006 to 2009.
Director at Enumeral Biomedical Corp.
Director at SELLAS Life Sciences Group, Inc. Lead Independent Director at Intra-Cellular Therapies, Inc. from 2014 to 2025.
Chief Compliance Officer & Senior Vice President at OSI Pharmaceuticals, Inc. from 2005 to 2007.
Chief Financial Officer & Executive Vice President at Applied Genetics, Inc. Dermatics from 2007 to 2008.
Chief Financial Officer & Executive Vice President at Aureon Biosciences, Inc. in 2010.
Manager at Touche Ross & Co. Chief Financial Officer & Executive Vice President at Aureon Laboratories, Inc. Education includes undergraduate degree from Long Island University.